Next-generation “armored” CAR T cell therapy shows promising results in lymphoma patients

This post was originally published on News-medical.net

You will shortly be re-directed to the publisher's website

A next-generation “armored” CAR T cell therapy showed promising results in a small study of patients whose B-cell lymphomas continued to resist multiple rounds of other cancer treatments, including commercially available CAR T cell therapies.